Drug

Who makes paliperidone palmitate?

2 companies list paliperidone palmitate as a human prescription drug, including under the names Erzofri extended-release, INVEGA HAFYERA, INVEGA SUSTENNA, INVEGA TRINZA. Forms: injection; injection, suspension, extended release. Routes: intramuscular.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing paliperidone palmitate

CompanyFormsApplicationNDCsRegistered sites
Janssen Pharmaceuticals, Inc.injection; injection, suspension, extended releaseNDANDA022264, NDA207946110
Shandong Luye Pharmaceutical Co LTDChinainjectionNDANDA21635261

Bulk ingredient listings

Orange Book patents

8 unexpired patents list paliperidone palmitate as the active ingredient, expiring between Jan 2031 and Nov 2041. Application holders: JANSSEN PHARMACEUTICALS INC, LUYE INNOMIND PHARMA (SHIJIAZHUANG) CO LTD.

Enquiry

Common questions

Who makes paliperidone palmitate?
2 companies list paliperidone palmitate as a human prescription drug in the openFDA NDC Directory, led by Janssen Pharmaceuticals, Inc., Shandong Luye Pharmaceutical Co LTD. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies paliperidone palmitate active ingredient?
11 companies list paliperidone palmitate as a bulk ingredient, including Interquim, S.A., Aurobindo Pharma Limited, Curia India Private Limited, Dr. Reddy's Laboratories Limited.